Study C-009 is designed to explore the effect of daily administration of OP0201 in patients with COME, a non-infectious form of otitis media.
Read More
Net Revenue of $15.4M, Up from $13.0M in Prior Quarter.
Read More
Investors are recognizing that KALY’s technology is undervalued.Â
Read More
With Canada legalizing cannabis infused beverages this month, PURA is moving forward with its already designed THC Savor beverage.
Read More
Under the terms of the Agreement, Herbfluence has selected two of the Company’s CBD branded products to be included in the initial launch of the Herbfluence marketing platform on Monday, October 28, 2019.
Read More
Get stock alerts, news & related alerts straight to your inbox!